Original articleUrogenital tumorsPrognostic factors of survival and rapid progression in782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie
Urogenital tumors
Under an Elsevier user license
open archive
Keywords
interferon
interleukin-2
metastatic renal carcinoma
prognostic factor
rapid progression
survival
Cited by (0)
- †
Groupe Français d’Immunothérapie investigators are listed in the Acknowledgements.
Copyright © 2002 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.